'OCD chopping board' could make condition worse

By Admin
Share
A revolutionary chopping board which is on sale at Selfridges stores in the UK has received criticism from those suffering with Obsessive Compulsive Di...

A revolutionary chopping board which is on sale at Selfridges stores in the UK has received criticism from those suffering with Obsessive Compulsive Disorder (OCD), reports The Independent.

The chopping board has been designed by US manufacturers Fred & Friends and is designed to resolve ‘sandwich problems’ for OCD sufferers.

For those who “want to cut their sandwich at a perfect 45 degree angle” or in a rigidly straight line, the board is covered with grid lines, scales and a protractor with marked angles.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

However, a leading OCD charity in the UK says the product could worsen the disease.

Ashley Fulwood, the Chief Executive of OCD-UK, told the newspaper: “The chopping board is cashing in on the debilitating nature of OCD.”

“It probably wasn't intended to be offensive, but it's in bad taste to stock this item.

“If it had been an HIV chopping board or a cancer cutting board, there would be an outcry,” he added.

“As a therapy technique, its use would be counter-productive. The manufacturer doesn't realise the impact OCD can have; it can ruin people's lives, careers and families.”

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare